Credit Suisse Ag Mirum Pharmaceuticals, Inc. Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
A detailed history of Credit Suisse Ag transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 25,207 shares of MIRM stock, worth $867,877. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,207
Previous 24,078
4.69%
Holding current value
$867,877
Previous $710,000
10.85%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MIRM
# of Institutions
184Shares Held
54.3MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$224 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$150 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$114 Million1.34% of portfolio
-
State Street Corp Boston, MA2.82MShares$97.2 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$95.3 Million0.04% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.27B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...